Compare TTI & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TTI | PLSE |
|---|---|---|
| Founded | 1981 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 1996 | 2015 |
| Metric | TTI | PLSE |
|---|---|---|
| Price | $7.95 | $22.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $10.40 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 1.7M | 306.8K |
| Earning Date | 05-28-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.17 | $912.86 |
| Revenue Next Year | $10.41 | $259.66 |
| P/E Ratio | $411.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $12.56 |
| 52 Week High | $12.54 | $26.30 |
| Indicator | TTI | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 31.53 | 61.71 |
| Support Level | $6.88 | $13.75 |
| Resistance Level | $8.27 | $26.30 |
| Average True Range (ATR) | 0.49 | 1.26 |
| MACD | -0.10 | 0.11 |
| Stochastic Oscillator | 0.42 | 83.77 |
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.